1. OP0250 Can rankl serum levels predict future progression to rheumatoid arthritis in acpa negative patients?. (15th June 2017) Authors: Burska, A; El-Jawhari, J; Tan, AL; Wakefield, R; Marzo-Ortega, H; Conaghan, P; Emery, P; Ponchel, F; Freeston, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0284 Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the avert trial. (15th June 2017) Authors: Ahmad, H; Baker, J; Østergaard, M; Emery, P; Durez, P; Ye, J; Banerjee, S; Conaghan, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PP001 Ultrasound To Guide Treatment Decisions In Rheumatoid Arthritis. (2017) Authors: Simpson, E; Stevenson, Matt; Hock, Emma; Wong, Ruth; Wakefield, R; Conaghan, P; Estrach, C; Edwards, C Journal: International journal of technology assessment in health care Issue: Volume 33:Supplement 1(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0104 Both MRI and HAQ-DI can predict relapses following all treatment withdrawal in MTX-NAÏVE patients with RA in remission after 12 months of abatacept therapy in the avert trial. (15th June 2017) Authors: Ahmad, H; Baker, J; Østergaard, M; Emery, P; Huizinga, T; Ye, J; Banerjee, S; Conaghan, P Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗